Albemarle Slips 1.71% as Shares Extend Monthly Loss
The specialty chemicals company's shares fell more than the broader market, while consensus forecasts point to higher quarterly sales and earnings.
Makkler Newsroom · Oct 1, 01:43 AM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $135.24 (+44.6%)
Prices may be delayed and are for informational purposes only - not investment advice.
The specialty chemicals company's shares fell more than the broader market, while consensus forecasts point to higher quarterly sales and earnings.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.